Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-23-043982

Chief Financial Officer sold 1,245 shares at $9.65 ($12,020)

  • Chief Financial Officer acquired 4,886 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

van Houte Hans · Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-07-30 Exercise or conversion : show line 1 in the form +2,886 81,816 D
2023-07-30 Exercise or conversion : show line 2 in the form +2,000 83,816 D
2023-07-31 Sale : show line 3 in the form −1,245 $9.65 $12,020 82,571 D
Open-market sales · 1,245 sh · avg $9.65 · $12,020

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-07-30 Exercise or conversion : show line 4 in the form Restricted Stock Units −2,886 28,861 D
2023-07-30 Exercise or conversion : show line 5 in the form Restricted Stock Units −2,000 22,000 D
Loading xslF345X05/doc4.xml…